Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Archerdx, Bio-Rad, Cochlear, Invivoscribe, Ortho, Quidel, Theradiag, Thermedical.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 10x Genomics, 20/20 Genesystems, AACC, Adaptas Solutions, Avero Diagnostics, Biodesix, Curative, Diaceutics, Diethelmkellersiberhegner, ERT, Flatiron Health, Foundation Medicine, Froedtert, Genentech, Inovalon, Korvalabs, L3harris, Oxford Immunotec Global, Partitalia, Physitrack, Roche, Royal Philips, Rewalk Robotics, Sensor ID, Shanghai Biotechnology Devices, Translational Genomics Institute, Ubiquitome, Viraxclear, Zenitas Healthcare.

Med-tech firms raising money in public or private financings, including: Alcon, Atia Vision, Boston Scientific, Cathvision, Chromacode, Medx Health.

Responding to COVID-19’s wakeup call as it exposes the risks of relying heavily on foreign biopharma supply chains, the U.S. Department of Health and Human Services (HHS) signed a four-year, $354 million agreement with a team of private industry partners, led by Phlow Corp., to expand U.S. manufacturing of essential medicines at risk of shortage during the pandemic and in future public health emergencies.

LONDON - EMA Director General Guido Rasi has hit out at the lack of coordination in COVID-19 clinical trials, questioning if the huge number of small studies that are running will support regulatory decision-making.

Representing the highest amount ever raised by a public biopharma company on a U.S. exchange, Moderna Inc. priced a $1.34 billion follow-on offering to help fund worldwide manufacturing and distribution of its mRNA-1273 vaccine for COVID-19.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Kempharm, Novartis, Organicell, Theralase, Tolero.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abnova, Adjuvance, Aetion, Be The Match, Cabaletta, Centivax, Cytodyn, Dyne, Genocea, Match, Haliodx, Imcheck, Innovation Pharmaceuticals, Ipsen, Innovent, Merck & Co., Nantkwest, Onxeo, Oragenics, Pharmajet, Primary Peptides, Prellis, Promis, Qingdao Primedicine, Revance, Rising Pharma, Ritter, Sernova, Shionogi, Sophiris, Therapix, Timber, Xenetic.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agios, Amplyx, Arbutus, Biogen, Covis, Hepion, Lidds, Mezzion, MGB Biopharma.